AB
QTTB icon

Amalgamated Bank’s Q32 Bio QTTB Stock Holding History

Amalgamated Bank’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-209
Closed – – 3174
2025
Q1 		$0 Hold
209
– – ﹤0.01% 2968
2024
Q4 		$1K Hold
209
– – ﹤0.01% 2970
2024
Q3 		$9K Hold
209
– – ﹤0.01% 2527
2024
Q2 		$4K Buy
+209
New +$5K ﹤0.01% 2898
2022
Q2 		– Sell
-282
Closed -$15K – 3226
2022
Q1 		$15K Buy
+282
New +$17.5K ﹤0.01% 2885

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amalgamated Bank's QTTB Position: Q2 2025 in Review

Amalgamated Bank sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 209 shares.

Amalgamated Bank first reported a position in QTTB in Q1 2022 and held it in 5 quarters. The position peaked at $15K in Q1 2022. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • Amalgamated Bank reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 209 Q32 Bio shares in Q2 2025.
  • Amalgamated Bank first reported a position in Q32 Bio in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Q32 Bio position peaked at $15K in Q1 2022.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.